Request Demo
Last update 30 May 2025
XZP-5955
Last update 30 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms XZP-5955 |
Target |
Action inhibitors |
Mechanism NTRK inhibitors(Neurotrophic tyrosine kinase receptor inhibitors), ROS1 inhibitors(Proto-oncogene tyrosine-protein kinase ROS inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with XZP-5955NCT04996121
The Safety Tolerability Pharmacokinetic Characteristics and Efficacy of XZP-5955 Tablets in Patients With NTRK or ROS1 Gene Fusion Locally Advanced or Metastatic Solid Tumors in a Single-arm Open-label Multi-center Phase I/II Clinical Study
100 Clinical Results associated with XZP-5955
Login to view more data
100 Translational Medicine associated with XZP-5955
Login to view more data
100 Patents (Medical) associated with XZP-5955
Login to view more data
100 Deals associated with XZP-5955
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Locally Advanced Lung Non-Small Cell Carcinoma | Phase 2 | China | 06 Dec 2021 | |
| metastatic non-small cell lung cancer | Phase 2 | China | 06 Dec 2021 | |
| NTRK fusion-positive solid tumors | Phase 2 | China | 06 Dec 2021 | |
| Liver Cancer | Phase 2 | China | 18 Nov 2021 | |
| ROS1 positive Mesothelioma | Phase 2 | China | 18 Nov 2021 | |
| Reactive oxygen species 1 positive non-small cell lung cancer | Phase 1 | China | 30 Jan 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free